Our mission is to help biopharma and biotech conduct high quality in vivo preclinical testing of newly discovered anti-cancer treatments in support of R&D project goals and timelines. Beviglia Cancer Models (BCM) is highly sensitive to Client's project goals, expectations, and timelines and fully available to work in an absolutely unique collaborative fashion while maintaining high level of confidentiality. BCM ensures that the progress of each experiment is followed closely and communicated with the Client immediately on a daily basis to enable any necessary and timely revision of the experimental design and changes to avoid missing important results. BCM offers also monitoring capabilities of studies contracted out to facilitate both project execution and delivery of results releasing Directors and VPs from the burden and time-consuming task of overseeing studies done at contract facilities. The President of BCM is always available to help with project and problem solving needs and is continuously striving to build long-term relationships with Clients; is highly motivated, trusted visionary “out of the box” very reliable, transparent, honest, and persistent, adds always care and personal touch to any contract work, and develops a sense of accountability toward the Clients. During her career, the President and Manager has successfully made significant contributions to advancement of drug lead candidates from discovery to clinical development. During the past years she has helped a number of investigators to advance their research by providing reliable and reproducible data through the provided services; those data were utilized for filing patents, presentations at scientific meetings, preparing IND filing prior to clinical trials, presenting to investors, and submitting grant proposals to NIH and other agencies. Her knowledge, skills, creativity, scientific rigor and diligence are key features in all services provided.